Insights from the Blog
GE Healthcare Life Sciences explores why Rainbow markers are a good choice when carrying out a Western blot.Continue reading
GE Healthcare Life Sciences and Guangzhou Development District Jointly Establish Guangzhou Bioprocess Academy
GE Healthcare Life Sciences and Guangzhou Development District government will jointly invest $10 million to establish a training center for biopharmaceutical professionals and students. The facility will be inaugurated as early as September 2020, and is expected to deliver training to more than 1,000 people annually.
This is a serious but inspirational story where a few brave souls blazed the trail and are now paying it forward. This is the story of Emily Whitehead, the first CAR T pediatric patient. And this is the story of Nicole Gularte, the leukemia patient who received CAR T cell therapy three times! Support the Emily Whitehead Foundation and Nicole by donating here by 23 Nov.
The KUBio “factory in a box” is expanding to accelerate the accessibility of biotherapeutics on a global scale. Additional modular platforms will be introduced in 2020 allowing biopharma manufacturers to quickly scale up vaccines, viral vector-based therapies, and other novel modalities.